Daniele Piomelli, PhD, Professor of Pharmacology at the University of California at Irvine, told Reuters in 2000:

“We think that by targeting cannabinoid receptors in the upper airways we can control coughs in a number of conditions…That’s important because most treatments currently available basically act on the brain cough center, a small region of the brain that is the target for codeine and similar drugs.”